- Home
- AENT vs TRDA Comparison
AENT vs TRDA Comparison
Compare AENT & TRDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AENT
- TRDA
- Stock Information
- Founded
- AENT 1990
- TRDA 2016
- Country
- AENT United States
- TRDA United States
- Employees
- AENT N/A
- TRDA N/A
- Industry
- AENT Durable Goods
- TRDA Biotechnology: Pharmaceutical Preparations
- Sector
- AENT Consumer Discretionary
- TRDA Health Care
- Exchange
- AENT Nasdaq
- TRDA Nasdaq
- Market Cap
- AENT 254.3M
- TRDA 220.1M
- IPO Year
- AENT N/A
- TRDA 2021
- Fundamental
- Price
- AENT $5.32
- TRDA $6.14
- Analyst Decision
- AENT Strong Buy
- TRDA Strong Buy
- Analyst Count
- AENT 1
- TRDA 3
- Target Price
- AENT $10.00
- TRDA $25.67
- AVG Volume (30 Days)
- AENT 40.8K
- TRDA 283.8K
- Earning Date
- AENT 09-18-2025
- TRDA 08-06-2025
- Dividend Yield
- AENT N/A
- TRDA N/A
- EPS Growth
- AENT N/A
- TRDA N/A
- EPS
- AENT 0.23
- TRDA N/A
- Revenue
- AENT $1,072,641,000.00
- TRDA $79,476,000.00
- Revenue This Year
- AENT N/A
- TRDA N/A
- Revenue Next Year
- AENT $2.01
- TRDA N/A
- P/E Ratio
- AENT $22.62
- TRDA N/A
- Revenue Growth
- AENT N/A
- TRDA N/A
- 52 Week Low
- AENT $1.10
- TRDA $4.93
- 52 Week High
- AENT $11.57
- TRDA $21.79
- Technical
- Relative Strength Index (RSI)
- AENT 52.90
- TRDA 54.29
- Support Level
- AENT $4.58
- TRDA $5.23
- Resistance Level
- AENT $5.97
- TRDA $5.47
- Average True Range (ATR)
- AENT 0.42
- TRDA 0.41
- MACD
- AENT -0.02
- TRDA 0.11
- Stochastic Oscillator
- AENT 53.03
- TRDA 90.30
About AENT Alliance Entertainment Holding Corporation
Alliance Entertainment Holding Corp is a top-tier distributor of music, movies, and consumer electronics. It offers products consisting of vinyl records, compact discs, DVDs, Blu-rays, and video games. The company serves customers of every size, providing a suite of services to resellers and retailers around the world.
About TRDA Entrada Therapeutics Inc.
Entrada Therapeutics Inc clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The Company's Endosomal Escape Vehicle (EEV)-therapeutics are designed to enable the efficient delivery of a wide range of therapeutics into a variety of organs and tissues, resulting in an improved therapeutic index. Its pipeline includes solutions for Neuromuscular Disease, Beyond Neuromuscular, and Platform Expansion.